Neurogene (NGNE) Depreciation & Amortization (CF) (2013 - 2026)
Neurogene posted quarterly Depreciation & Amortization (CF) of $847000.0 for Q1 2026, up 13.08% year-on-year from $749000.0 in Q1 2025, and up 15.55% on a QoQ basis from $733000.0 in Q4 2025.
Neurogene (NGNE) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $847000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 13.08% year-over-year to $847000.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 0.98% YoY), and the FY2025 full-year result was $3.0 million, down 6.25% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $847000.0, up from $733000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2.0 million in Q4 2022 and bottomed at $323000.0 in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $800000.0 (2023), against an average of $797411.8.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) surged 413.59%; it then tumbled 59.21% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.0 million in 2022, then sank by 59.21% to $817000.0 in 2023, then fell by 2.08% to $800000.0 in 2024, then fell by 8.38% to $733000.0 in 2025, then climbed by 15.55% to $847000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $847000.0 (Q1 2026), $733000.0 (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Neurogene | 632.14 Mn | 632.14 Mn | - | 847,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 847,000.00 |
| Mar 31, 2026 | 847,000.00 |
| Dec 31, 2025 | 733,000.00 |
| Dec 31, 2025 | 733,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 749,000.00 |
| Mar 31, 2025 | 749,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 814,000.00 |
| Mar 31, 2024 | 814,000.00 |
| Dec 31, 2023 | 817,000.00 |
| Dec 31, 2023 | 817,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 323,000.00 |
| Sep 30, 2022 | 323,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 411,000.00 |
| Mar 31, 2022 | 411,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 356,000.00 |
| Sep 30, 2021 | 356,000.00 |
| Jun 30, 2021 | 313,000.00 |
| Jun 30, 2021 | 313,000.00 |
| Mar 31, 2021 | 247,000.00 |
| Mar 31, 2021 | 247,000.00 |
| Dec 31, 2020 | 207,000.00 |
| Dec 31, 2020 | 207,000.00 |
| Sep 30, 2020 | 188,000.00 |
| Sep 30, 2020 | 188,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Dec 31, 2019 | 160,000.00 |
| Dec 31, 2019 | 160,000.00 |
| Sep 30, 2019 | 98,000.00 |
| Sep 30, 2019 | 98,000.00 |
| Jun 30, 2019 | 41,000.00 |
| Jun 30, 2019 | 41,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Dec 31, 2014 | 20,456.00 |
| Dec 31, 2014 | 20,456.00 |
| Sep 30, 2014 | 25,314.00 |
| Sep 30, 2014 | 25,314.00 |
| Jun 30, 2014 | 71,938.00 |
| Jun 30, 2014 | 71,938.00 |
| Mar 31, 2014 | 18,238.00 |
| Mar 31, 2014 | 18,238.00 |
| Dec 31, 2013 | 14,373.00 |
| Dec 31, 2013 | 14,373.00 |
| Sep 30, 2013 | 14,821.00 |
| Sep 30, 2013 | 14,821.00 |
| Jun 30, 2013 | 15,592.00 |
| Jun 30, 2013 | 15,592.00 |
| Mar 31, 2013 | 14,785.00 |
| Mar 31, 2013 | 14,785.00 |